Scientific Progress in Oncology and Supportive Care
Explore the importance of research programs addressing complications associated with intensive cancer treatment and the role of supportive care in clinical development.
Explore Research →Discover company announcements, scientific developments, research perspectives and important updates from across DOR BioPharma's biopharmaceutical programs.
Explore Latest News ↗Stay informed about DOR BioPharma's scientific activities, development priorities, collaborations and milestones. Our news platform brings together updates reflecting our commitment to advancing biopharmaceutical science and addressing important unmet clinical needs.
Scientific progress depends on rigorous research, clinical insight and collaboration. Explore the principles guiding DOR BioPharma's development activities across oncology, gastrointestinal research, supportive care and biodefense.
Discover Our Research Approach →Explore the importance of research programs addressing complications associated with intensive cancer treatment and the role of supportive care in clinical development.
Explore Research →Discover research priorities involving gastrointestinal conditions, including acute GI GVHD, pediatric Crohn's disease and inflammatory bowel diseases.
Explore Research →Learn about the role of scientific innovation, research capabilities and collaborative initiatives in supporting preparedness against serious biological threats.
Explore Research →Scientific partnerships connect expertise, research institutions and clinical perspectives to support the development of innovative biopharmaceutical programs.
Discover Partnerships →A closer look at the research principles, development philosophy and scientific priorities that shape DOR BioPharma's work.
Our Mission →Why understanding clinical needs is an important part of developing focused scientific programs and meaningful research strategies.
Learn More →Explore the scientific themes that inform DOR BioPharma's development strategy and ongoing research interests.
Research perspectives on supportive care and scientific approaches to complications associated with intensive cancer treatment.
Scientific developments and research priorities involving inflammatory bowel conditions and gastrointestinal complications.
Scientific preparedness, research initiatives and collaborative approaches addressing biological threats.
October 11, 2011 · Formation of a Pediatric Crohn's Disease Medical Advisory Board to help guide research priorities and scientific development.
August 12, 2011 · Announcement of second-quarter financial results and key accomplishments supporting the company's development strategy.
Ongoing focus on biopharmaceutical research, scientific collaboration and development activities across the company's areas of interest.
Connecting scientific knowledge and institutional expertise to advance research initiatives.
Encouraging collaboration around important clinical research priorities and development needs.
Building connections across scientific communities and organizations working toward shared objectives.
Interested in our research areas, company developments or potential scientific partnerships? Discover our work and connect with our team.
CONTACT OUR TEAM ↗